Betaxolol 0.5% eye drops

Nchi: Uingereza

Lugha: Kiingereza

Chanzo: MHRA (Medicines & Healthcare Products Regulatory Agency)

Viambatanisho vya kazi:

Betaxolol hydrochloride

Inapatikana kutoka:

DE Pharmaceuticals

ATC kanuni:

S01ED02

INN (Jina la Kimataifa):

Betaxolol hydrochloride

Kipimo:

5mg/1ml

Dawa fomu:

Eye drops

Njia ya uendeshaji:

Ocular

Darasa:

No Controlled Drug Status

Dawa ya aina:

Valid as a prescribable product

Bidhaa muhtasari:

BNF: 11060000

Tabia za bidhaa

OBJECT 1
BETAXOLOL 0.5% EYE DROPS
Summary of Product Characteristics Updated 10-Mar-2017 | FDC
International Ltd
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Betaxolol 0.5% Eye Drops
2. Qualitative and quantitative composition
Active Ingredient
Betaxolol
5.0 mg/ml
(as Betaxolol
hydrochloride
5.6 mg/ml)
Excipient(s) with known effect
Benzalkonium chloride 0.01%w/v
For a full list of excipients, see section 6.1
3. Pharmaceutical form
Eye drops, solution
4. Clinical particulars
4.1 Therapeutic indications
Reduction of elevated intraocular pressure in conditions such as
ocular hypertension and chronic open-
angle glaucoma.
4.2 Posology and method of administration
Adults (including the elderly): recommended therapy is one drop of
Betaxolol 0.5% Eye Drops to be
instilled into the affected eye(s) twice a day.
Children: No clinical studies have been performed to establish safety
and efficacy in children. Therefore,
this product is currently not recommended for use in childre